Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
5.95
-0.03 (-0.50%)
Apr 13, 2026, 2:59 PM AST

TADAWUL:9626 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
45.4633.9226.5221.92
Revenue Growth (YoY)
34.02%27.88%20.99%-
Cost of Revenue
32.1422.918.1915.02
Gross Profit
13.3111.028.336.9
Selling, General & Admin
5.264.062.482.57
Operating Expenses
5.264.062.742.69
Operating Income
8.066.965.594.21
Interest Expense
-0.75-0.34-0.36-0.29
Interest & Investment Income
0.840.1--
Other Non Operating Income (Expenses)
0.070.06-0.3-
EBT Excluding Unusual Items
8.216.784.933.92
Gain (Loss) on Sale of Assets
0.04---
Other Unusual Items
--00.13-
Pretax Income
8.256.785.063.92
Income Tax Expense
0.940.480.190.14
Net Income
7.36.34.873.78
Net Income to Common
7.36.34.873.78
Net Income Growth
15.93%29.40%28.71%-
Shares Outstanding (Basic)
181210-
Shares Outstanding (Diluted)
181210-
Shares Change (YoY)
56.17%21.59%--
EPS (Basic)
0.400.550.51-
EPS (Diluted)
0.400.550.51-
EPS Growth
-25.77%6.42%--
Free Cash Flow
4.766.664.075.24
Free Cash Flow Per Share
0.260.580.43-
Gross Margin
29.29%32.50%31.41%31.46%
Operating Margin
17.72%20.53%21.07%19.20%
Profit Margin
16.07%18.58%18.36%17.26%
Free Cash Flow Margin
10.47%19.64%15.34%23.90%
EBITDA
9.097.596.24.54
EBITDA Margin
19.99%22.37%23.36%20.71%
D&A For EBITDA
1.030.620.610.33
EBIT
8.066.965.594.21
EBIT Margin
17.72%20.53%21.07%19.20%
Effective Tax Rate
11.45%7.11%3.69%3.56%
Advertising Expenses
0.310.15--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.